dc.creator | Baracat, Juliana S | |
dc.creator | Teixeira, Cleber E | |
dc.creator | Okuyama, Cristina E | |
dc.creator | Priviero, Fernanda B M | |
dc.creator | Faro, Renato | |
dc.creator | Antunes, Edson | |
dc.creator | De Nucci, Gilberto | |
dc.date | 2003-Sep | |
dc.date | 2015-11-27T12:52:28Z | |
dc.date | 2015-11-27T12:52:28Z | |
dc.date.accessioned | 2018-03-29T00:58:05Z | |
dc.date.available | 2018-03-29T00:58:05Z | |
dc.identifier | European Journal Of Pharmacology. v. 477, n. 2, p. 163-9, 2003-Sep. | |
dc.identifier | 0014-2999 | |
dc.identifier | | |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/14519420 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/195547 | |
dc.identifier | 14519420 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1295780 | |
dc.description | 5-Cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4-ylamine (BAY 41-2272) is a potent soluble guanylyl cyclase stimulator in a nitric oxide (NO)-independent manner. The relaxant effect of BAY 41-2272 was investigated in rabbit and human corpus cavernosum in vitro. BAY 41-2272 (0.01-10 microM) relaxed both rabbit (pEC(50)=6.82+/-0.06) and human (pEC(50)=6.12+/-0.10) precontracted cavernosal strips. The guanylyl cyclase inhibitor (ODQ, 10 microM) caused significant rightward shifts in the concentration-response curves for BAY 41-2272 in rabbit (4.7-fold) and human (2.3-fold) tissues. The NO synthesis inhibitor (N-nitro-L-arginine methyl ester (L-NAME), 100 microM) also produced similar rightward shifts, revealing that BAY 41-2272 acts synergistically with endogenous NO to elicit its relaxant effect. The results also indicate that ODQ is selective for the NO-stimulated enzyme, since relaxations evoked by BAY 41-2272 were only partly attenuated by ODQ. The present study shows that both BAY 41-2272 and sildenafil evoke relaxations independent of inhibition of haem in soluble guanylate cyclase. Moreover, there is no synergistic effect of the two compounds in corpus cavernosum. | |
dc.description | 477 | |
dc.description | 163-9 | |
dc.language | eng | |
dc.relation | European Journal Of Pharmacology | |
dc.relation | Eur. J. Pharmacol. | |
dc.rights | fechado | |
dc.rights | | |
dc.source | PubMed | |
dc.subject | Adolescent | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Animals | |
dc.subject | Cyclic Amp | |
dc.subject | Drug Synergism | |
dc.subject | Enzyme Activators | |
dc.subject | Guanylate Cyclase | |
dc.subject | Humans | |
dc.subject | In Vitro Techniques | |
dc.subject | Isometric Contraction | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Muscle Relaxation | |
dc.subject | Ng-nitroarginine Methyl Ester | |
dc.subject | Nitric Oxide | |
dc.subject | Nitric Oxide Synthase | |
dc.subject | Oxadiazoles | |
dc.subject | Penis | |
dc.subject | Pyrazoles | |
dc.subject | Pyridines | |
dc.subject | Rabbits | |
dc.title | Relaxing Effects Induced By The Soluble Guanylyl Cyclase Stimulator Bay 41-2272 In Human And Rabbit Corpus Cavernosum. | |
dc.type | Artículos de revistas | |